BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32154924)

  • 1. High triple-negative breast cancer prevalence and aggressive prognostic factors in Barbadian women with breast cancer.
    Hercules SM; Hercules JC; Ansari A; Date SAJ; Skeete DHA; Smith Connell SP; Pond GR; Daniel JM
    Cancer; 2020 May; 126(10):2217-2224. PubMed ID: 32154924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the genomic landscapes of Barbadian and Nigerian women with triple negative breast cancer.
    Hercules SM; Liu X; Bassey-Archibong BBI; Skeete DHA; Smith Connell S; Daramola A; Banjo AA; Ebughe G; Agan T; Ekanem IO; Udosen J; Obiorah C; Ojule AC; Misauno MA; Dauda AM; Egbujo EC; Hercules JC; Ansari A; Brain I; MacColl C; Xu Y; Jin Y; Chang S; Carpten JD; Bédard A; Pond GR; Blenman KRM; Manojlovic Z; Daniel JM
    Cancer Causes Control; 2022 Jun; 33(6):831-841. PubMed ID: 35384527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial and regional disparities of triple negative breast cancer incidence rates in the United States: An analysis of 2011-2019 NPCR and SEER incidence data.
    Zhang W; Bai Y; Sun C; Lv Z; Wang S
    Front Public Health; 2022; 10():1058722. PubMed ID: 36530732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent trends in racial and regional disparities in cervical cancer incidence and mortality in United States.
    Yoo W; Kim S; Huh WK; Dilley S; Coughlin SS; Partridge EE; Chung Y; Dicks V; Lee JK; Bae S
    PLoS One; 2017; 12(2):e0172548. PubMed ID: 28234949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kaiso is highly expressed in TNBC tissues of women of African ancestry compared to Caucasian women.
    Bassey-Archibong BI; Hercules SM; Rayner LGA; Skeete DHA; Smith Connell SP; Brain I; Daramola A; Banjo AAF; Byun JS; Gardner K; Dushoff J; Daniel JM
    Cancer Causes Control; 2017 Nov; 28(11):1295-1304. PubMed ID: 28887687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translational Epidemiology: An Integrative Approach to Determine the Interplay Between Genetic Ancestry and Neighborhood Socioeconomic Status on Triple Negative Breast Cancer.
    Goel N; Yadegarynia S; Kwon D; Kesmodel SB; Harbour JW; Kobetz E; Merchant N; Rodriguez DA
    Ann Surg; 2022 Sep; 276(3):430-440. PubMed ID: 35758508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher population-based incidence rates of triple-negative breast cancer among young African-American women : Implications for breast cancer screening recommendations.
    Amirikia KC; Mills P; Bush J; Newman LA
    Cancer; 2011 Jun; 117(12):2747-53. PubMed ID: 21656753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are there differences in outcomes by race among women with metastatic triple-negative breast cancer?
    Oppong BA; Rolle AA; Ndumele A; Li Y; Fisher JL; Bhattacharyya O; Adeyanju T; Paskett ED
    Breast Cancer Res Treat; 2022 Nov; 196(2):399-408. PubMed ID: 36152139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple-negative breast cancer incidence in the United States: ecological correlations with area-level sociodemographics, healthcare, and health behaviors.
    Moss JL; Tatalovich Z; Zhu L; Morgan C; Cronin KA
    Breast Cancer; 2021 Jan; 28(1):82-91. PubMed ID: 32671723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on triple-negative breast cancer disparities for the United States: A population-based study from the United States Cancer Statistics database, 2010 through 2014.
    Scott LC; Mobley LR; Kuo TM; Il'yasova D
    Cancer; 2019 Oct; 125(19):3412-3417. PubMed ID: 31282032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Features of triple-negative breast cancer: Analysis of 38,813 cases from the national cancer database.
    Plasilova ML; Hayse B; Killelea BK; Horowitz NR; Chagpar AB; Lannin DR
    Medicine (Baltimore); 2016 Aug; 95(35):e4614. PubMed ID: 27583878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial Disparities in Triple Negative Breast Cancer: A Review of the Role of Biologic and Non-biologic Factors.
    Prakash O; Hossain F; Danos D; Lassak A; Scribner R; Miele L
    Front Public Health; 2020; 8():576964. PubMed ID: 33415093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Race differences in cardiovascular disease and breast cancer mortality among US women diagnosed with invasive breast cancer.
    Troeschel AN; Liu Y; Collin LJ; Bradshaw PT; Ward KC; Gogineni K; McCullough LE
    Int J Epidemiol; 2019 Dec; 48(6):1897-1905. PubMed ID: 31155644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproductive factors and the risk of triple-negative breast cancer in white women and African-American women: a pooled analysis.
    Ma H; Ursin G; Xu X; Lee E; Togawa K; Duan L; Lu Y; Malone KE; Marchbanks PA; McDonald JA; Simon MS; Folger SG; Sullivan-Halley J; Deapen DM; Press MF; Bernstein L
    Breast Cancer Res; 2017 Jan; 19(1):6. PubMed ID: 28086982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial cancer risk and trends among distinct African descent populations.
    Medina HN; Penedo FJ; Joachim C; Deloumeaux J; Koru-Sengul T; Macni J; Bhakkan B; Peruvien J; Schlumbrecht MP; Pinheiro PS
    Cancer; 2023 Sep; 129(17):2717-2726. PubMed ID: 37357566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status.
    Howlader N; Altekruse SF; Li CI; Chen VW; Clarke CA; Ries LA; Cronin KA
    J Natl Cancer Inst; 2014 Apr; 106(5):. PubMed ID: 24777111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial Differences in 21-Gene Recurrence Scores Among Patients With Hormone Receptor-Positive, Node-Negative Breast Cancer.
    Holowatyj AN; Cote ML; Ruterbusch JJ; Ghanem K; Schwartz AG; Vigneau FD; Gorski DH; Purrington KS
    J Clin Oncol; 2018 Mar; 36(7):652-658. PubMed ID: 29341832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
    Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
    JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial disparities in uterine and ovarian carcinosarcoma: A population-based analysis of treatment and survival.
    Rojas C; Tian C; Powell MA; Chan JK; Bateman NW; Conrads TP; Rocconi RP; Jones NL; Shriver CD; Hamilton CA; Maxwell GL; Casablanca Y; Darcy KM
    Gynecol Oncol; 2020 Apr; 157(1):67-77. PubMed ID: 32029291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple-negative breast cancer in African-American women: disparities versus biology.
    Dietze EC; Sistrunk C; Miranda-Carboni G; O'Regan R; Seewaldt VL
    Nat Rev Cancer; 2015 Apr; 15(4):248-54. PubMed ID: 25673085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.